CN102600235A - Chinese medicinal eye drop for treating oculopathy - Google Patents
Chinese medicinal eye drop for treating oculopathy Download PDFInfo
- Publication number
- CN102600235A CN102600235A CN2012100996013A CN201210099601A CN102600235A CN 102600235 A CN102600235 A CN 102600235A CN 2012100996013 A CN2012100996013 A CN 2012100996013A CN 201210099601 A CN201210099601 A CN 201210099601A CN 102600235 A CN102600235 A CN 102600235A
- Authority
- CN
- China
- Prior art keywords
- eye
- parts
- eye drop
- oculopathy
- fel ursi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicinal eye drop for treating oculopathy is colorless transparent solution prepared by mixing leaching solution and Fel Ursi powder. The leaching solution is prepared from (by weight parts) 3-5 parts of Semen Cassiae, 3-5 parts of Herba Senecionis Scandentis, 1.5-3 parts of Radix Angelicae Sinensis, 1.5-3 parts of Prunellae Spica and 1-4 parts of Herba Chlorophyti by pulverizing and leaching. The leaching solution is subjected to distillation purification and sterilization, mixed with the Fel Ursi powder at ratio of 10 mL:(0.5-1.5) g, and hermetically packaged with plastic bottle. The eye drop is administered at dosage of 1-2 drops/eye for 2-3 times daily. The eye drop has obvious and rapid effects on common oculopathy such as keratitis, muscae volitantes, pterygium, acute hemorrhagic conjunctivitis, epiphora with wind, eye swelling and pain, trachoma, and blur vision, with short treatment course and no toxic side effects.
Description
Technical field
The present invention is a kind of Chinese medicine eye drop, a kind of Chinese medicine composition drop of treating oculopathy.
Background technology
For common disease of eye such as keratitis, eye muscae volitantes, nebula shape bulbar conjunctiva polyp, pink eye disease, epiphora induced by wind, swelling around the eyes pain, sand holes, blurred vision; Existing medicine is the eye drop of antibiotics mostly; Like erythromycin eye drop, chloromycetin eye drop; Perhaps spongaion resembles the ointment of chlortetracycline, oxytetracycline, chloromycetin etc., belongs to Western medicine class medicament for the eyes.Though the Western medicine curative effect is very fast, the efficacy of a drug is concentrated, and as other Western medicine, side effect is comparatively obvious, and curative effect lasting time is short, belongs to rigid curative effect.Chinese medicine then is the active component compound action of multiple flavour of a drug, though curative effect is slow slightly, duration of efficacy is long, and stable curative effect belongs to soft curative effect.
For the treatment of oculopathy, use the rarely found report of Chinese medicine at present.Basic reason is that people are still few to this area research, and eyes are the responsive organ that body weight for humans is wanted in addition, dare not try out Chinese medicine easily, so that does not also have the Chinese medicine eye drop of molding to occur so far.In fact, suitable Chinese medicine eye drop is to treatment oculopathy, and particularly above-mentioned common oculopathy is of great use, and curative effect also is significantly, on many ancient books this is had a lot of records.But many Chinese medicine medicament for the eyes prescriptions are all lost, and people can't know now how Chinese ancients prepare medicament for the eyes.
Summary of the invention
The object of the invention is exactly to propose a kind of Chinese medicine composition drop of treating oculopathy; This drop has obvious curative effects to oculopathy such as pink eye disease, nebula shape bulbar conjunctiva polyp, eye muscae volitantes, sand holes; Short treating period and having no side effect is to fill up the blank of no Chinese medicine eye drop in the prior art.
The Chinese medicine composition drop of this treatment oculopathy of the present invention is characterized in that it is the solution after following flavour of a drug are done infusion and Fel Ursi powder after the ratio assembly by weight of former medicine and exchanged uniform:
Semen Cassiae 3-5 part, Herba Senecionis Scandentis 3-5 part, Radix Angelicae Sinensis 1.5-3 part, Spica Prunellae 1.5-3 part; Infusion is purified and sterilization through distillation, and the gained distillate is blended into Fel Ursi powder in the ratio of every 10ml:0.5-1.5g.
Can also add Herba Chlorophyti 1-4 part in the above-mentioned prescription and participate in water logging together.
For making medical material leach active component fast, soak after each pulverizing medicinal materials of distinguishing the flavor of.
The same with common collyrium packing, the distillate of having converted Fel Ursi powder packs with little plastic bottle.
Chinese medicine composition drop of the present invention is a colourless transparent liquid, does not have significant difference with common Western medicine class eye drop in appearance.Usage and consumption: directly splash in the frame, each every eyes 1-2 drips, and day drips 2-3 time.
This Chinese medicine composition eye drop of the present invention is reasonably combined by Chinese medicine medicines; Extracting wherein through water logging, active component forms; The combination drug effect is fairly obvious; To the instant effect of common disease of eye such as above-mentioned keratitis, eye muscae volitantes, nebula shape bulbar conjunctiva polyp, pink eye disease, epiphora induced by wind, swelling around the eyes pain, sand holes, blurred vision, short treating period has no side effect.Wherein:
The Fel Ursi powder bitter in the mouth is cold in nature, goes into liver and gall heart channel, has liver heat removing and eyesight improving, relieve dizziness, high fever, infantile convulsions, epilepsy, etc. relieve the pain, the effect of heat-clearing and toxic substances removing, among the peoplely be commonly used to treat diseases such as pyretic toxicity skin ulcer pain, conjunctival congestion cataracta, extreme heat causing wind syndrome, the present invention with it as monarch drug.The equal bitter in the mouth of Semen Cassiae and Herba Senecionis Scandentis is cold in nature, has the effect of heat-clearing and toxic substances removing, liver heat removing and eyesight improving, and Semen Cassiae also has the function of removing the necrotic tissue and promoting granulation and antiphlogistic and bactericidal.The present invention is a ministerial drug with this two flavors medicine.
The Radix Angelicae Sinensis sweet in the mouth is warm in nature, returns liver heart spleen channel, and the effect of promoting blood circulation and stopping pain is arranged, the present invention with it as adjuvant drug.
Spica Prunellae acrid in the mouth, hardship, cold in nature, return the warp of liver and gall, the effect of clearing away liver-fire Disperse hepatic depression is arranged, among the peoplely be commonly used to treat conjunctival congestion and swelling pain.The present invention with it as messenger drug.
Herba Chlorophyti acrid in the mouth property is flat, and abnormal smells from the patient delicate fragrance has eliminating inflammation and expelling toxin, an effect of invigorate blood circulation arresting lacrimation and pain relieving.The present invention with it as messenger drug.
Prove that through clinic trial the present invention all is superior to single flavour of a drug to the curative effect of above-mentioned oculopathy, wide adaptability, combination back function obviously strengthens, and indication is wide, and curative effect is fast and stable.
The specific embodiment
Further specify the preparation process of medicinal liquid of the present invention below with instance, and its obvious curative effects.
With Semen Cassiae, Herba Senecionis Scandentis, Radix Angelicae Sinensis, Spica Prunellae is three groups of medical materials by proportioning separately interval low end value, intermediate value and high end value assembly respectively; The water logging that adds 2 times of each medical material weight sums was respectively steeped 3-5 days; Medicinal residues are dragged for, and the clarification soak distills the distillate of purifying transparently respectively with distillator.The distillate that the medical material proportioning is got low end value exchanges uniform by the dissolving of every 10ml adding 1.5g Fel Ursi powder, gets No. 1 eye drop (No. 1 drop).The distillate that the medical material proportioning is got intermediate value by every 10ml add the dissolving of 1g Fel Ursi powder exchange uniform No. 2 eye drops (No. 2 drops).The distillate that the medical material proportioning is got high end value by every 10ml add the dissolving of 0.5g Fel Ursi powder exchange uniform No. 3 eye drops (No. 3 drops).
On the basis of No. 2 corresponding medical materials of eye drop, add 1 part, 2 parts in Herba Chlorophyti and 4 parts of participation immersions, all the other conditions are constant.The gained distillate is blended into behind the Fel Ursi powder gained eye drip and drips and be respectively 4-1 number, 4-2 number and 4-3 number, closes and claims No. 4 eye drops (No. 4 drops).
Be case below with No. 1 eye drop:
Example 1, Lee so-and-so, the woman, 49 years old, Mengzi, Yunnan city resident, nearly more than 2 years since, frequent conjunctival congestion and swelling pain, epiphora induced by wind, the existing nebula shape bulbar conjunctiva polyp of ophthalmic causes blurred vision.Once arrived the treatment of city hospital admission, the doctor is its treatment with medicament for the eyes commonly used such as chloromycetin eyedrops, erythromycin eye ointment, profit are easypro, glittering, does not feel any better.Began on November 8th, 2010 with making No. 1 eye drop treatment of the present invention, usage and dosage as above.Symptom all disappears after 2 months, and patient and family are very satisfied per capita.
Example 2, make pottery so-and-so, the woman, 36 years old, Mengzi, Yunnan city root of Dahurian angelica villages and small towns peasant suffered from serious pink eye disease, and eyes are red and swollen, often press against pain, and tear stream is more than.Once in commune hospital, locality town, certain military hospital treated, curative effect is all undesirable, symptom still exists.On August 18th, 2010, find the inventor through friend's introduction, require with drop treatment of the present invention.The inventor is its treatment with No. 1 eye drop promptly, and tear has not filled after 1 month, and eyes have unconsciously been pressed against, and swell and ache to have disappeared.It is clear to look thing, and vision restoration is normal.
Example 3, Yang, the woman, 42 years old, scientific research institution, city, Mengzi, Yunnan families of workers and staff caused the yellow abnormal pigmentary deposit on the skin pathological changes in optical fundus owing to suffer from hypertension, and blurring of vision seemingly has foreign body keeping off eyes.2012 days 11, use No. 1 eye drop treatment of the present invention, two all backsight things have become clear, and foreign body sensation disappears at the moment.
Example 4, beat up sun certain, woman, 67 years old, Mengzi, Yunnan city resident, the long-term dry and astringent pain of eyes, blurred vision.Use No. 1 eye drop of the present invention one all backs state of an illness greatly to alleviate, the transference cure of the dry and astringent pain of itching is looked thing and is become clear.
Be to use the case of No. 2 eye drops below:
Example 5, Wu, the man, 42 years old, the township peasant was reined in northwest, city, Mengzi, Yunnan, trikes ophthalmic, and eyes are red and swollen, nebula shape bulbar conjunctiva polyp occurs, dim eyesight, blurring of vision has had a strong impact on its work and life.The Nikkei people introduced and found the inventor Augusts 20 in 2011, was its treatment with No. 2 eye drops of the present invention promptly, and symptom all disappears after the week.Patient is very grateful.
The example 6, Gong so-and-so, man, 52 years old, Mengzi, Yunnan people from city.Nebula shape bulbar conjunctiva polyp appears in the oculopathy that happens suddenly between in January, 2005, and the white at present mist of eyeball is dry and astringent, presses against the pain twinge, blurred vision.Only know in the morbidity that with some common collyrium treatments like chloromycetin, erythromycin, chlortetracycline collyrium, spongaion etc. were wherein also used to it is believed that it is the special good Germany of curative effect, the import liquid medicine of the U.S..But DeGrain, symptom lose all the time and disappear.Between in JIUYUE, 2005, begin No. 2 eye drop treatments with the present invention.Usage and dosage as above.Use after 1 month continuously to begin to manifest curative effect, bulbar conjunctiva polyp begins to diminish, and the pain of pressing against thorn alleviates gradually, and white burn-off is lost.After 2 months, bulbar conjunctiva polyp disappears totally basically, does not press against the pain of thorn, and it is clear to look thing, and eyes are no longer dry and astringent.It is normal that vision has been recovered fully.
Example 7, Luo, the woman, 54 years old, the workman of Chongqing City railway unit, diabetes cause dim eyesight, eye is dried, eye is puckery, sees distinguished and admirable tear, blurred vision because of suffering from.Medication once is countless, does not feel any better.On March 25th, 2012 began with the treatment of No. 2 eye drops of the present invention upon somebody's introduction, conscious improvement after 3 days, and symptom obviously alleviates, and imperceptible eye xerophthalmia is puckery after the week, sees that wind also no longer sheds tears, and eye is no longer colored, and it is clear to look thing.For consolidating curative effect, the inventor advises still on her reuse that 1 month medicine is in case bounce-back.
Example 8, sweet so-and-so, the woman, 28 years old, the workman of Guangdong Shuande unit between private prosecution in August, 2009, caused visual deterioration, blurring of vision because of suffering from other diseases.Through treatment after a while,, fallen oculopathy though main disease is cured.The medication of seeking medical advice everywhere loses exactly and is clearly better.Began No. 2 eye drop treatments on April 26th, 2011 with the present invention, conscious improvement to some extent after 2 days, thing is looked in medication to the in the time of 3 days clear gradually, and cardinal symptom disappears basically.One week back vision restoration normal.
Example 9, what so-and-so, woman, 70 years old, Guiyang, Guizhou private hospital doctor, president.Because the long-term diabetes of suffering from, it is muddy to cause eye vitreous, the existing moth in the visual field.Medication once is countless, has seen many well-known doctors, loses exactly to be clearly better.On February 19th, 2011 began with the treatment of trying of No. 2 eye drops of the present invention, and as the doctor, it is half-believing, half-doubting that this patient begins, and believes not too how many effects the present invention has, just know do not have detrimental effect after an inadequate usefulness.Do not expect that the mosquito that flies in the 3rd day visual field of medication has just obviously reduced, and looks thing and begins to become clear.It is more and more obvious to continue the medication effect afterwards, after 1 month symptom fully controlled with alleviate.After knowing curative effect of the present invention, this patient promptly proposes with president's identity, sign common development agreement with the inventor, together eye drop of the present invention is developed to formal medicament for the eyes.
Be to use the instance of No. 3 eye drops below:
Example 10, king so-and-so, the man, 50 years old, Mengzi, Yunnan city rain was crossed shop town peasant, suffers from keratitis for a long time, ophthalmic has nebula shape bulbar conjunctiva polyp, eye is normal feels dry and astringent, also sheds tears twinge, blurred vision.On December 23rd, 2011, introduce the inventor place through friend and seek medical advice.The inventor is its treatment with No. 3 eye drops of the present invention promptly.Continuous use after one month bulbar conjunctiva polyp obviously diminish, rough measuring and calculating is so small to have only original 1/3rd, dry and astringent alleviating no longer sheds tears, twinge disappears.Bulbar conjunctiva polyp cannot see trace basically during to 2012 2 the end of month.For consolidating curative effect, the inventor advises that this patient continues to use 2-3 month medicine, in case recurrence.
Example 11, Lee, the man, 51 years old, Mengzi, Yunnan city resident, prominent sense dim eyesight between in August, 2011, eye is puckery, and eye is pressed against, and looking thing can not be lasting, blurred vision.In late August, 2011 its lumbar intervertebral disc prolapse that comes to seek medical advice upon somebody's introduction, in treatment, learn eye drop good effect of the present invention, have the phychology of trying in arms and wanted the autonomy of going home of No. 3 eye drops of two bottles.Above-mentioned symptom has all disappeared after I had never expected 5 days, and the patient has the patient of ophthalmic to come to cure to invention with regard to having introduced 3 after seeing tangible effect.The inventor has cured with same eye drop.
Example 12, pay certain, the woman, 40 years old, Chenjiazhai, city, Mengzi, Yunnan peasant, existing nebula shape Nu is 5 years in the eyes, and dim eyesight, eye are pressed against, eye is puckery, the white mist of companion's eyeball, blurred vision was once used various common medicament for the eyes water droplet mistakes, also beat a lot of pin water, all loseed to be clearly better.Between in July, 2011, the cervical spondylosis of seeking medical advice to the inventor place is upon somebody's introduction learnt eye drop of the present invention of great use, accidentally so seek medical advice.Treat all backsight things continuously with No. 3 eye drops of the present invention and begin to become clear, the symptom that the puckery eye of dim eyesight eye is pressed against disappears basically.After the medication 1 month, eyes have recovered health.
Be case below with No. 4 eye drops:
Example 13, Lee, woman, 29 years old, people from Beijing, certain secretary of mechanism.On January 8th, 2010, the inventor participates in " Chinese medicine forum " session this patient of understanding to the capital.This patient just suffered from " pink eye disease " at that time, and eyes are red and swollen, and pain is ashamed of facing with the people unbearably.After learning liquid medicine of the present invention, have the mood of trying in arms and wanted bottle 4-1 liquid medicine treatment to the inventor.Symptom is with regard to complete obiteration two days later.
Example 14, Gong, woman, 14 years old, middle school, city, Mengzi, Yunnan students.Between in August, 2011, the classmate who is suffered from " pink eye disease " is infected, and it is red and swollen that eye once becomes, twinge.Just cured fully in two days through the treatment of inventor 4-2 eye drop.Then this patient brings 5 classmates with disease of the same class to come to seek medical advice, and the inventor successively cured to them at 2-3 days with 4-3 liquid medicine.Prove on the eye drop curative effect of No. 4 three countermarks in the eye drop and do not have significant difference.
The described healing of above case, rehabilitation refer to the symptom complete obiteration, the imperceptible slight illness of patient, and sensory recovery has arrived normality.
Claims (4)
1. Chinese medicine composition drop of treating oculopathy is characterized in that it is the solution after following flavour of a drug are done infusion and Fel Ursi powder after the ratio assembly by weight of former medicine and exchanged uniform:
Semen Cassiae 3-5 part, Herba Senecionis Scandentis 3-5 part, Radix Angelicae Sinensis 1.5-3 part, Spica Prunellae 1.5-3 part; Infusion is purified and sterilization through distillation, and the gained distillate is blended into Fel Ursi powder in the ratio of every 10ml:0.5-1.5g.
2. Chinese medicine composition drop of treating oculopathy is characterized in that it is the clear solution after following flavour of a drug are done infusion and Fel Ursi powder after the ratio assembly by weight of former medicine and exchanged uniform:
Semen Cassiae 3-5 part, Herba Senecionis Scandentis 3-5 part, Radix Angelicae Sinensis 1.5-3 part, Spica Prunellae 1.5-3 part, Herba Chlorophyti 1-4 part; Infusion is purified and sterilization through distillation, and the gained distillate is blended into Fel Ursi powder in the ratio of every 10ml:0.5-1.5g.
3. the Chinese medicine composition drop of treatment oculopathy according to claim 1 and 2 soaks after the pulverizing medicinal materials that it is characterized in that respectively distinguishing the flavor of.
4. the Chinese medicine composition drop of treatment oculopathy according to claim 1 and 2 is characterized in that the distillate of having converted Fel Ursi powder packs with little plastic bottle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100996013A CN102600235B (en) | 2012-04-09 | 2012-04-09 | Chinese medicinal eye drop for treating oculopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100996013A CN102600235B (en) | 2012-04-09 | 2012-04-09 | Chinese medicinal eye drop for treating oculopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102600235A true CN102600235A (en) | 2012-07-25 |
| CN102600235B CN102600235B (en) | 2013-08-21 |
Family
ID=46518254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100996013A Expired - Fee Related CN102600235B (en) | 2012-04-09 | 2012-04-09 | Chinese medicinal eye drop for treating oculopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102600235B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524068A (en) * | 2014-12-19 | 2015-04-22 | 马京平 | Traditional Chinese medicine eye drops for treating pinkeye and preparation method |
| CN107737283A (en) * | 2017-12-06 | 2018-02-27 | 韦永朴 | A kind of Chinese medicine composition for treating disease of shedding tears and preparation method thereof |
| CN110201028A (en) * | 2019-07-17 | 2019-09-06 | 山东瞳仁健康科技有限责任公司 | A kind of ointment and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1628759A (en) * | 2004-10-13 | 2005-06-22 | 凌沛学 | Chinese medicinal formulation for treating asthenopia syndrome and its preparation method |
| CN1965877A (en) * | 2006-11-06 | 2007-05-23 | 赵因 | Chinese medicinal eye drop for treating bacteria and virus infected conjunctivitis |
| CN102362924A (en) * | 2011-10-23 | 2012-02-29 | 长春中医药大学 | Medicinal composition for treating ophthalmic diseases and preparation method thereof |
-
2012
- 2012-04-09 CN CN2012100996013A patent/CN102600235B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1628759A (en) * | 2004-10-13 | 2005-06-22 | 凌沛学 | Chinese medicinal formulation for treating asthenopia syndrome and its preparation method |
| CN1965877A (en) * | 2006-11-06 | 2007-05-23 | 赵因 | Chinese medicinal eye drop for treating bacteria and virus infected conjunctivitis |
| CN102362924A (en) * | 2011-10-23 | 2012-02-29 | 长春中医药大学 | Medicinal composition for treating ophthalmic diseases and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 南京中医药大学: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104524068A (en) * | 2014-12-19 | 2015-04-22 | 马京平 | Traditional Chinese medicine eye drops for treating pinkeye and preparation method |
| CN107737283A (en) * | 2017-12-06 | 2018-02-27 | 韦永朴 | A kind of Chinese medicine composition for treating disease of shedding tears and preparation method thereof |
| CN110201028A (en) * | 2019-07-17 | 2019-09-06 | 山东瞳仁健康科技有限责任公司 | A kind of ointment and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102600235B (en) | 2013-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101716214B (en) | Medical composition containing dandelion extract as well as novel application and preparation method thereof | |
| CN103393969B (en) | Eye drop used for releasing eye fatigue and preparation method thereof | |
| CN100540022C (en) | A kind of Chinese medicine preparation for the treatment of early diabetic retinopathy | |
| CN103961556A (en) | Dendrobium officinale oculentum for relieving asthenopia | |
| CN102362924B (en) | Medicinal composition for treating ophthalmic diseases and preparation method thereof | |
| CN102166203B (en) | Eye pad for alleviating eye fatigue and preparation method thereof | |
| CN102600235B (en) | Chinese medicinal eye drop for treating oculopathy | |
| CN102293953B (en) | Ovientvine, chrysanthemum and stiff silkworm decoction for treating idiopathic facial palsy | |
| CN105106318B (en) | A kind of Chinese medicine composition and preparation method thereof for treating xerophthalmia | |
| CN107753554A (en) | A kind of prepared slices of Chinese crude drugs for eyeshield | |
| CN105796925A (en) | Pure traditional Chinese medicine eye patch | |
| CN103720857A (en) | Traditional Chinese medicinal preparation for treating fundus macular oedema lesion | |
| CN110859895A (en) | Eye ointment and preparation method thereof | |
| CN105168446A (en) | Traditional Chinese medicinal composition for treating eye diseases, eye beauty adding bag as well as preparation methods of traditional Chinese medicinal composition and eye beauty adding bag | |
| CN105560891A (en) | Traditional Chinese medicine eye drops containing borneol and preparation method thereof | |
| CN101468114A (en) | Product for protecting vision and method for preparing the same | |
| CN107080786A (en) | Antidepressant compositions and its preparation method and application and medicine or pharmaceutical composition comprising it | |
| CN104147380A (en) | Pharmaceutical composition for relieving asthenopia, preparation method and applications thereof | |
| CN1899339B (en) | Medicinal composition for treating acute and chronic conjunctivitis for eye and its preparing method | |
| CN101229244B (en) | Adjuvant therapy rheumatoid arthritis external medicine and preparing method thereof | |
| CN100577187C (en) | Chinese medicine preparation for treating eye fatigue and its preparing process | |
| CN104055841B (en) | A kind for the treatment of and pre-myopic-preventing pharmaceutical composition | |
| CN104173456B (en) | Chinese medicine composition for the treatment of facial neuritis and its preparation method and application | |
| CN100389782C (en) | Eyesight-improving capsule and preparation process thereof | |
| CN103550357B (en) | A kind of control muscae volitantes collyrium and its production and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130821 Termination date: 20190409 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |